Helen Won

16.8k citations

61 papers · 4.3k · 3 hit papers · h-index 28

Impact in

Cancer Research top 1%
- Cancer Genomics and Diagnostics
Oncology top 1%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research

Papers in

Molecular Biology 22
- PI3K/AKT/mTOR signaling in cancer 6
- Melanoma and MAPK Pathways 4
Oncology 19
- Lung Cancer Research Studies 7
- HER2/EGFR in Cancer Research 5

Co-authors: Michael F. Berger (37 shared papers)Marc Ladanyi (12 shared papers)Sarat Chandarlapaty (6 shared papers)José Baselga (5 shared papers)Marie Will (1 shared paper)Zhiqiang Li (1 shared paper)Kinisha Gala (1 shared paper)Weiyi Toy (1 shared paper)
Journals: Journal of Clinical Microbiology (7 papers)Cancer Research (7 papers)Journal of Clinical Oncology (6 papers)Clinical Cancer Research (5 papers)Annals of Oncology (4 papers)
Partner nations: United States United Kingdom Belgium

In The Last Decade

Helen Won

60 papers receiving 4.2k citations

Helen Won's Hit Papers

align trajectories log scale

High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden 2019 · 309 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Clinical Cancer Research
2016 Clinical Cancer Research
2013 Nature Genetics

Peers

Countries citing papers authored by Helen Won

Since Specialization

Citations

This map shows the geographic impact of Helen Won's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Won with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Won more than expected).

Fields of papers citing papers by Helen Won

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Won. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Won. The network helps show where Helen Won may publish in the future.

Co-authors

The 25 scholars most cited alongside Helen Won, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Helen Won Line = papers co-authored together Helen Won links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	ESR1 ligand-binding domain mutations in hormone-resistant breast cancer Nature Genetics ·Weiyi Toy, Yang Shen, Helen Won, Bradley Green, Rita A. Sakr, Marie Will, Zhiqiang Li, Kinisha Gala, Sean W. Fanning, Tari A. King, Clifford A. Hudis, David Chen, Tetiana Taran, Gabriel N. Hortobágyi, Geoffrey L. Greene, Michael F. Berger, José Baselga, Sarat Chandarlapaty Hit paper breakdown →	2013	901
2	Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor Nature ·Vanessa Rodrik-Outmezguine, Masanori Okaniwa, Zhan Yao, Chris J. Novotny, Claire McWhirter, Arpitha Banaji, Helen Won, Wai Wong, (unknown), Elisa de Stanchina, Derek Barratt, Sabina Cosulich, Teresa Klinowska, Neal Rosen, Kevan M. Shokat	2016	360
3	Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets Clinical Cancer Research ·Natasha Rekhtman, M. Catherine Pietanza, Matthew D. Hellmann, Jarushka Naidoo, Arshi Arora, Helen Won, Darragh Halpenny, Hangjun Wang, Shaozhou K. Tian, Anya M. Litvak, Paul K. Paik, Alexander Drilon, Nicholas D. Socci, John T. Poirier, Ronglai Shen, Michael F. Berger, André L. Moreira, William D. Travis, Charles M. Rudin, Marc Ladanyi Hit paper breakdown →	2016	341
4	High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden Clinical Cancer Research ·Ryma Benayed, Michael Offin, Kerry Mullaney, Purvil Sukhadia, Kelly Rios, Patrice Desmeules, Ryan Ptashkin, Helen Won, Jason C. Chang, Darragh Halpenny, Alison M. Schram, Charles M. Rudin, David M. Hyman, Maria E. Arcila, Michael F. Berger, Ahmet Zehir, Mark G. Kris, Alexander Drilon, Marc Ladanyi Hit paper breakdown →	2019	309
5	Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle Annals of Oncology ·Leticia De Mattos‐Arruda, Britta Weigelt, Javier Cortés, Helen Won, Charlotte K.Y. Ng, Paolo Nucíforo, François‐Clément Bidard, Claudia Aura, Cristina Saura, Vicente Peg, Salvatore Piscuoglio, Mafalda Oliveira, Yvonne H. C. M. Smolders, Pragi Patel, Larry Norton, Josep Tabernero, Michael F. Berger, Joan Seoane, Jorge S. Reis‐Filho	2014	299
6	A Phase Ib Study of Alpelisib (BYL719), a PI3Kα-Specific Inhibitor, with Letrozole in ER+/HER2− Metastatic Breast Cancer Clinical Cancer Research ·Ingrid A. Mayer, Vandana G. Abramson, Luigi Formisano, Justin M. Balko, Mónica V. Estrada, Melinda E. Sanders, Dejan Juric, David B. Solit, Michael F. Berger, Helen Won, Yisheng Li, Lewis C. Cantley, Eric P. Winer, Carlos L. Arteaga	2016	250
7	Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK Dependence Cancer Research ·Moriah H. Nissan, Christine A. Pratilas, Alexis M. Jones, Ricardo J. Ramirez, Helen Won, Cailian Liu, Shakuntala Tiwari, Li Ren Kong, Aphrothiti J. Hanrahan, Zhan Yao, Taha Merghoub, Antoni Ribas, Paul B. Chapman, Rona Yaeger, Barry S. Taylor, Nikolaus Schultz, Michael F. Berger, Neal Rosen, David B. Solit	2014	227
8	Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome–associated Renal Cancer The American Journal of Surgical Pathology ·Ying‐Bei Chen, A. Rose Brannon, Antoun Toubaji, Mária Dudás, Helen Won, Hikmat Al‐Ahmadie, Samson W. Fine, Anuradha Gopalan, Norma Frizzell, Martin H. Voss, Paul Russo, Michael F. Berger, Satish K. Tickoo, Victor E. Reuter	2014	202
9	Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases Cancer Discovery ·Paul K. Paik, Ronglai Shen, Helen Won, Natasha Rekhtman, Lu Wang, Camelia S. Sima, Arshi Arora, Venkatraman Seshan, Marc Ladanyi, Michael F. Berger, Mark G. Kris	2015	117
10	Small-Cell Lung Cancers in Patients Who Never Smoked Cigarettes Journal of Thoracic Oncology ·Anna M. Varghese, Maureen F. Zakowski, Helena A. Yu, Helen Won, Gregory J. Riely, Lee M. Krug, Mark G. Kris, Natasha Rekhtman, Marc Ladanyi, Lu Wang, Michael F. Berger, M. Catherine Pietanza	2014	103
11	Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology Modern Pathology ·Paul Weisman, Charlotte K.Y. Ng, Edi Brogi, R. Eisenberg, Helen Won, Salvatore Piscuoglio, Maria Rosaria De Filippo, Rafael A Ioris, Muzaffar Akram, Larry Norton, Britta Weigelt, Michael F. Berger, Jorge S. Reis‐Filho, Hannah Y. Wen	2016	92
12	Clinical and molecular characterization of patients with cancer of unknown primary in the modern era Annals of Oncology ·Anna M. Varghese, Arshi Arora, Marinela Capanu, Niedzica Camacho, Helen Won, Ahmet Zehir, Jianjiong Gao, Debyani Chakravarty, Nikolaus Schultz, David S. Klimstra, Marc Ladanyi, David M. Hyman, David B. Solit, Michael F. Berger, Leonard B. Saltz	2017	80
13	Rapid Identification of Biothreat and Other Clinically Relevant Bacterial Species by Use of Universal PCR Coupled with High-Resolution Melting Analysis Journal of Clinical Microbiology ·Samuel Yang, Padmini Ramachandran, Richard E. Rothman, Yu‐Hsiang Hsieh, Andrew Hardick, Helen Won, Aleksandar Kecojević, Joany Jackman, Charlotte A. Gaydos	2009	72
14	Will Patients “Opt In” to Perform Their Own Rapid HIV Test in the Emergency Department? Annals of Emergency Medicine ·Charlotte A. Gaydos, Yu‐Hsiang Hsieh, Leah Harvey, Avanti Burah, Helen Won, Mary Jett‐Goheen, Mathilda Barnes, Patricia Agreda, (unknown), Richard E. Rothman	2011	68
15	Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer Cancer Cell ·Craig M. Bielski, Mark T.A. Donoghue, Mayur Gadiya, Aphrothiti J. Hanrahan, Helen Won, Matthew T. Chang, Philip Jonsson, Alexander Penson, Alexander N. Gorelick, Christopher Harris, Alison M. Schram, Aijazuddin Syed, Ahmet Zehir, Paul B. Chapman, David M. Hyman, David B. Solit, Kevin Shannon, Sarat Chandarlapaty, Michael F. Berger, Barry S. Taylor	2018	63
16	A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer Lung Cancer ·M. Catherine Pietanza, Anya M. Litvak, Anna M. Varghese, Lee M. Krug, Martin Fleisher, Jerrold B. Teitcher, Andrei I. Holodny, Cami S. Sima, Kaitlin M. Woo, Kenneth Ng, Helen Won, Michael F. Berger, Mark G. Kris, Charles M. Rudin	2016	57
17	Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2) Modern Pathology ·Jaclyn F. Hechtman, Weiguo Liu, Justyna Sadowska, Lisa Zhen, Laetitia Borsu, Maria E. Arcila, Helen Won, Ronak Shah, Michael F. Berger, Efsevia Vakiani, Jinru Shia, David S. Klimstra	2015	53
18	Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway Cancer ·Maria M. Rubinstein, David M. Hyman, Imogen Caird, Helen Won, Krysten Soldan, Kenneth Seier, Alexia Iasonos, William P. Tew, Roisin E. O’Cearbhaill, Rachel N. Grisham, Martee L. Hensley, Tiffany A. Troso-Sandoval, Paul Sabbatini, Joyce Guillen, S. Duygu Selçuklu, Catherine Zimel, Jean Torrisi, Carol Aghajanian, Vicky Makker	2019	52
19	Massively Parallel Sequencing Identifies Recurrent Mutations in TP53 in Thymic Carcinoma Associated with Poor Prognosis Journal of Thoracic Oncology ·André L. Moreira, Helen Won, Robert McMillan, James Huang, Gregory J. Riely, Marc Ladanyi, Michael F. Berger	2014	51
20	PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma JCO Precision Oncology ·Federica Catalanotti, Donavan T. Cheng, Alexander N. Shoushtari, Douglas B. Johnson, Katherine S. Panageas, Parisa Momtaz, Catherine Higham, Helen Won, James J. Harding, Taha Merghoub, Neal Rosen, Jeffrey A. Sosman, Michael F. Berger, Paul B. Chapman, David B. Solit	2017	51

About Helen Won

Helen Won is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Genetics, having authored 61 papers that have together received 4.3k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (12 papers), Lung Cancer Research Studies (7 papers), Lung Cancer Treatments and Mutations (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Advanced Breast Cancer Therapies (6 papers), HER2/EGFR in Cancer Research (5 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Melanoma and MAPK Pathways (4 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.6k citations), Pulmonary and Respiratory Medicine (1.2k citations), Molecular Biology (1.8k citations) and Pathology and Forensic Medicine (375 citations). Helen Won has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Michael F. Berger, Marc Ladanyi, Sarat Chandarlapaty, José Baselga, Marie Will, Zhiqiang Li, Kinisha Gala, Weiyi Toy, Yang Shen and Tari A. King. Their work appears in journals such as Journal of Clinical Microbiology, Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Helen Won

Impact in

Papers in i

In The Last Decade

Helen Won

Helen Won's Hit Papers

Peers

Countries citing papers authored by Helen Won

Fields of papers citing papers by Helen Won

All Works

About Helen Won

Explore authors with similar magnitude of impact

Papers in